Orca Bio to Present at the 43rd Annual J.P. Morgan Conference
06 Jan 2025 //
BUSINESSWIRE
Orca Bio: Three-Year Data for Orca-T® in Hematological Malignancies
08 Dec 2024 //
BUSINESSWIRE
Orca Bio: Phase 3 Precision-T Patient Enrollment Completed
05 Jun 2024 //
BUSINESSWIRE
Orca Bio Presents Promising Data on Orca-T in Two Oral Presentations
23 Feb 2024 //
BUSINESSWIRE
Orca Bio to Present at the 42nd Annual J.P. Morgan Healthcare Conference
03 Jan 2024 //
BUSINESSWIRE
Orca Presents Positive Data Demonstrating the Potential for Orca-T and Orca-Q
09 Dec 2023 //
BUSINESSWIRE
Orca Bio to Present at the 41st Annual J.P. Morgan Healthcare Conference
06 Jan 2023 //
BUSINESSWIRE
Orca Bio to Present Abstracts at American Society of Hematology Annual Meeting
03 Nov 2022 //
BUSINESSWIRE
Orca Bio to increase its cell therapy manufacturing capacity in Sacramento
08 Sep 2022 //
ENDPTS
Orca Bio Announces the Precision-T PIII Study at Transplant Centers Across U.S.
02 Aug 2022 //
BUSINESSWIRE
Orca Bio to Present New Clinical Data on Orca-T at EHA
12 May 2022 //
BUSINESSWIRE
Orca Bio Presents Positive Data Reinforcing Clinical Profile and Manufacturing
25 Apr 2022 //
BUSINESSWIRE
Orca Bio to Present New Clinical Data on Orca-T at the 63rd American Society
04 Nov 2021 //
BUSINESSWIRE
Orca Bio Announces Oral Presentation of Orca-T Clinical Data at the 62nd
04 Nov 2020 //
GLOBENEWSWIRE